![137735-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/137735-Thumbnail%20Image.png?versionId=p0eXeP2d03kcFVsH6Euhiot_ftbbE3Gt&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240614/us-west-2/s3/aws4_request&X-Amz-Date=20240614T171244Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=59292f0c61db9dd0f6fad453682f193d9c2d7b6018f4a2523a3f13fdd50cecc3&itok=v4vqSaHP)
![137273-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/137273-Thumbnail%20Image.png?versionId=Hu0K4Z1UUNTw5dQPNolgpjvNAy5jiqLb&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240606/us-west-2/s3/aws4_request&X-Amz-Date=20240606T101147Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=cda817c6ebc99ba1eabf93a5773e0c75d207e873997ad0f63b544588498d75ea&itok=E-z8Q_a2)
![137471-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/137471-Thumbnail%20Image.png?versionId=oBm7GR8SlMoe01GHGkxRpxffqdtTIygj&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240614/us-west-2/s3/aws4_request&X-Amz-Date=20240614T171244Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=4559ab9e0e7893b04a4275e191362932a202d2e816494fdfe5d803f01d33e3d3&itok=8MaqFm5-)
![136383-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/136383-Thumbnail%20Image.png?versionId=8mw7mU5tU5BCOrdQduIshTBHa4NeaKC.&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240530/us-west-2/s3/aws4_request&X-Amz-Date=20240530T153639Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=808c395d038204045b4b9e4a91fd50388a9989b2ab3eddbe50555a38eceebf76&itok=8GIPQD6d)
![136571-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/136571-Thumbnail%20Image.png?versionId=B_bmZ0K8fCXnwNcGlw_rvi7KyKtlyAbo&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T202724Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=5b3949d006bbdf5cf2c62b585b2759b527a29cd9e7b35db738f59734997844c5&itok=t-KZLV2M)
![141461-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-06/141461-Thumbnail%20Image.png?versionId=XX3tbFNKrPAxem2ubZXGWnxpb8BEujXZ&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240602/us-west-2/s3/aws4_request&X-Amz-Date=20240602T100830Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=17cfe72ea48448b83167e21b850f2da436defc089ec8aaf37a2409ed6f84e0ae&itok=GCq4Oc_J)
![148500-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-07/148500-Thumbnail%20Image.png?versionId=125A9Rnxu_gA2DecgxX1e2XCzJ1IsdWR&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T065555Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=9a54e65f3e0b0435d5c5e4bc91d53da83380c984232565fd3cc866888027fabb&itok=DVCXRfhn)
As life expectancy increases worldwide, age related diseases are becoming greater health concerns. One of the most prevalent age-related diseases in the United States is dementia, with Alzheimer’s disease (AD) being the most common form, accounting for 60-80% of cases. Genetics plays a large role in a person’s risk of developing AD. Familial AD, which makes up less than 1% of all AD cases, is caused by autosomal dominant gene mutations and has almost 100% penetrance. Genetic risk factors are believed to make up about 49%-79% of the risk in sporadic cases. Many different genetic risk factors for both familial and sporadic AD have been identified, but there is still much work to be done in the field of AD, especially in non-Caucasian populations. This review summarizes the three major genes responsible for familial AD, namely APP, PSEN1 and PSEN2. Also discussed are seven identified genetic risk factors for sporadic AD, single nucleotide polymorphisms in the APOE, ABCA7, NEDD9, CASS4, PTK2B, CLU, and PICALM genes. An overview of the main function of the proteins associated with the genes is given, along with the supposed connection to AD pathology.
![130350-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-04/130350-Thumbnail%20Image.png?versionId=w3dG6iWiJ7Jasvugcwrgw.8FSiNaZnFt&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240605/us-west-2/s3/aws4_request&X-Amz-Date=20240605T170724Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=5f6a567148781deda2b2127cea49a69bf03bb9d1363d553f03ee72983f413f09&itok=D7ID6Po8)
The membrane proximal region (MPR, residues 649–683) and transmembrane domain (TMD, residues 684–705) of the gp41 subunit of HIV-1’s envelope protein are highly conserved and are important in viral mucosal transmission, virus attachment and membrane fusion with target cells. Several structures of the trimeric membrane proximal external region (residues 662–683) of MPR have been reported at the atomic level; however, the atomic structure of the TMD still remains unknown. To elucidate the structure of both MPR and TMD, we expressed the region spanning both domains, MPR-TM (residues 649–705), in Escherichia coli as a fusion protein with maltose binding protein (MBP). MPR-TM was initially fused to the C-terminus of MBP via a 42 aa-long linker containing a TEV protease recognition site (MBP-linker-MPR-TM).
Biophysical characterization indicated that the purified MBP-linker-MPR-TM protein was a monodisperse and stable candidate for crystallization. However, crystals of the MBP-linker-MPR-TM protein could not be obtained in extensive crystallization screens. It is possible that the 42 residue-long linker between MBP and MPR-TM was interfering with crystal formation. To test this hypothesis, the 42 residue-long linker was replaced with three alanine residues. The fusion protein, MBP-AAA-MPR-TM, was similarly purified and characterized. Significantly, both the MBP-linker-MPR-TM and MBP-AAA-MPR-TM proteins strongly interacted with broadly neutralizing monoclonal antibodies 2F5 and 4E10. With epitopes accessible to the broadly neutralizing antibodies, these MBP/MPR-TM recombinant proteins may be in immunologically relevant conformations that mimic a pre-hairpin intermediate of gp41.
![130413-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-04/130413-Thumbnail%20Image.png?versionId=tJXUjihcltyAFFSvZBO4kgC.2HzOf6dB&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240614/us-west-2/s3/aws4_request&X-Amz-Date=20240614T172632Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=3ebe3652da4b53e483b69ee50757d852c8f91ea9252a6e4919d6f38eed55beeb&itok=vcotlMyV)
![132219-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-08/132219-Thumbnail%20Image.png?versionId=n9sfMdnhu0JeCnUVbbqOnhLUSJZTQHBB&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240614/us-west-2/s3/aws4_request&X-Amz-Date=20240614T203625Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=15fe78aa1f98ef3c352a65f6d98413188038fd70320dab4810ea54f2aba92552&itok=yh_o7div)